Published in Ann Med on November 03, 2010
Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes (2012) 1.02
Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care (2012) 0.95
Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study). Diabetes Care (2011) 0.87
Time-dependent alterations in rat macrovessels with type 1 diabetes. Exp Diabetes Res (2012) 0.83
Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy. EBioMedicine (2015) 0.81
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia-the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). J Hum Hypertens (2015) 0.80
Brachial and central blood pressure in HIV-infected subjects. Hypertens Res (2015) 0.77
Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes. J Diabetes Sci Technol (2016) 0.76
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population. Ther Adv Chronic Dis (2015) 0.75
Long non-coding RNA ASncmtRNA-2 is upregulated in diabetic kidneys and high glucose-treated mesangial cells. Exp Ther Med (2017) 0.75
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA (2005) 3.01
Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet (2004) 2.86
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes (2009) 2.80
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev (2011) 2.61
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care (2005) 2.26
Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care (2011) 2.20
The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16
Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia (2011) 2.07
Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study. Diabetologia (2015) 2.05
Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol (2005) 1.96
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol (2011) 1.82
Long-term leisure-time physical activity and serum metabolome. Circulation (2012) 1.81
Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80
New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet (2012) 1.79
Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71
Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension (2005) 1.67
Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens (2006) 1.62
Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care (2012) 1.57
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes (2009) 1.55
Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J Hypertens (2009) 1.53
Birth weight is inversely correlated to adult systolic blood pressure and pulse pressure in type 1 diabetes. Hypertension (2004) 1.51
1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 1.51
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes. Diabetes (2015) 1.40
Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes (2010) 1.39
Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes (2012) 1.36
High-throughput pedigree drawing. Eur J Hum Genet (2005) 1.36
Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care (2005) 1.35
RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) (2011) 1.32
Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes (2003) 1.29
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. Diabetes Care (2012) 1.26
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ (2011) 1.26